CLINICAL_TRIALS ClinicalTrials.gov record update

A First-In-Human, Single Arm, Open-label, Phase 1 Dose-Escalation Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06256055
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:21.002853+00:00
Published At: 2024-07-24T00:00:00+00:00
Record Updated At: 2024-07-24
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Malignant Mesothelioma", "Colorectal Cancer", "Bile Duct Cancer", "Rectal Cancer", "Ovary Cancer", "Pancreatic Cancer", "Breast Cancer Female"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-07-24"
protocolSection.identificationModule.nctId: "NCT06256055"
protocolSection.identificationModule.officialTitle: "A First-In-Human, Single Arm, Open-label, Phase 1 Dose-Escalation Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.